Evidence map›Paper›PMID 18617679›Full record

ArticleAmerican journal of respiratory cell and molecular biology2009

Regulation of COX-2 expression and IL-6 release by particulate matter in airway epithelial cells.

Yutong Zhao, Peter V Usatyuk, Irina A Gorshkova, Donghong He, Ting Wang, Liliana Moreno-Vinasco, Alison S Geyh, Patrick N Breysse, Jonathan M Samet, Ernst Wm Spannhake and 2 more

Abstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
3.0field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 103 citations in OpenAlex.

  1. Air pollution-induced airway epithelial barrier dysfunction in COPD: a narrative review of mechanisms and therapeutic implications.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  2. Article
  3. Seasonal PMParticle and fibre toxicology · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Antioxidant and Anti-Inflammatory Potential ofJournal of inflammation research · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Role of air pollutants in airway epithelial barrier dysfunction in asthma and COPD.European respiratory review : an official journal of the European Respiratory Society · 2022
    Review
  14. My Journey in Academia as a Lipid Biochemist.Cell biochemistry and biophysics · 2021
    Review
  15. Review
  16. Article
  17. Upregulation of COX-2 and PGEJournal of inflammation research · 2021
    Article
  18. Article
  19. Epigenetic Mechanisms of Inflammasome Regulation.International journal of molecular sciences · 2020
    Review
  20. The roles of autotaxin/lysophosphatidic acid in immune regulation and asthma.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Yutong ZhaoDepartment of Medicine, University of Chicago, Chicago, IL 60637, USA.
Peter V Usatyuk
Irina A Gorshkova
Donghong He
Ting Wang
Liliana Moreno-Vinasco
Alison S Geyh
Patrick N Breysse
Jonathan M Samet
Ernst Wm Spannhake
Joe G N Garcia
Viswanathan Natarajan
University of Chicago · USJohns Hopkins University · US

Funding

Lung Epithelial Inflammation by Lysophosphatidic AcidR01HL071152 · NHLBI · UNIVERSITY OF CHICAGO · PI NATARAJAN, VISWANATHAN · 2002 to 2005
$1.6M
NHLBI NIH HHS R01 HL071152
6 · The paper itself

Abstract

Particulate matter (PM) in ambient air is a risk factor for human respiratory and cardiovascular diseases. The delivery of PM to airway epithelial cells has been linked to release of proinflammatory cytokines; however, the mechanisms of PM-induced inflammatory responses are not well-characterized. This study demonstrates that PM induces cyclooxygenase (COX)-2 expression and IL-6 release through both a reactive oxygen species (ROS)-dependent NF-kappaB pathway and an ROS-independent C/EBPbeta pathway in human bronchial epithelial cells (HBEpCs) in culture. Treatment of HBEpCs with Baltimore PM induced ROS production, COX-2 expression, and IL-6 release. Pretreatment with N-acetylcysteine (NAC) or EUK-134, in a dose-dependent manner, attenuated PM-induced ROS production, COX-2 expression, and IL-6 release. The PM-induced ROS was significantly of mitochondrial origin, as evidenced by increased oxidation of the mitochondrially targeted hydroethidine to hydroxyethidium by reaction with superoxide. Exposure of HBEpCs to PM stimulated phosphorylation of NF-kappaB and C/EBPbeta, while the NF-kappaB inhibitor, Bay11-7082, or C/EBPbeta siRNA attenuated PM-induced COX-2 expression and IL-6 release. Furthermore, NAC or EUK-134 attenuated PM-induced activation of NF-kappaB; however, NAC or EUK-134 had no effect on phosphorylation of C/EBPbeta. In addition, inhibition of COX-2 partly attenuated PM-induced Prostaglandin E2 and IL-6 release.

Indexed as

AcetylcysteineBaltimoreCCAAT-Enhancer-Binding Protein-betaCyclooxygenase 2CytokinesDinoprostoneEpithelial CellsHumansInterleukin-6MitochondriaNF-kappa BOrganometallic CompoundsParticulate MatterReactive Oxygen SpeciesRespiratory MucosaRNA, Small InterferingAcetylcysteineCCAAT-Enhancer-Binding Protein-betaCyclooxygenase 2CytokinesDinoprostoneEUK-134Interleukin-6NF-kappa BOrganometallic CompoundsParticulate MatterPTGS2 protein, humanReactive Oxygen SpeciesRNA, Small InterferingSalicylates

Identifiers

PMID18617679
PMCPMC5459547
OpenAlexW2016623350

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.